Warfarin versus factor Xa inhibitors in the long-term treatment of cerebral venous sinus thrombosis a single-center retrospective analysis

Long-term anticoagulation in the treatment of Cerebral Venous Sinus Thrombosis (CVST) has revolved around the use of warfarin. The relatively recent introduction of Direct Oral Anticoagulants (DOACs), such as Factor Xa inhibitors, in treating CVSTs promises to offer numerous patient benefits. We aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Christodoulides, Alexei, Bohnstedt, Bradley N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234611/
https://www.ncbi.nlm.nih.gov/pubmed/35769920
http://dx.doi.org/10.1016/j.ensci.2022.100412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234611/
https://www.ncbi.nlm.nih.gov/pubmed/35769920
http://dx.doi.org/10.1016/j.ensci.2022.100412

Ejemplares similares